Pneumocystis carinii (PC) pneumonia remains a serious complication of HIV infection and other immunocompromised states including patients undergoing chemotherapy and solid organ transplant recipients. In the setting of HIV infection there is a well-known inverse relationship between CD4+ lymphocyte count and the risk of both PC infection and bacterial pneumonia. In the last funding period we have defined the effector T-cell lineages required for the protection against PCP as well as developed molecular adjuvants using gene products expressed by CD4+ T-cells to investigate whether these molecules could proyide B cell help in the absence of peripheral CD4+ lymphocytes. Using DNA vaccination with an immunodominant antigen identified in the last funding cycle, KEX1, we have screened IFNg (Thi), lL-4 (Th2), IL-17 and IL-21 (Thi 7) as well as CD40L (expressed on activated T-cells) to elicit anti-PC antibody responses, and protection against PCP in CD4-depleted mice. Among these molecules, CD40L was the most effective on eliciting antigen specific IgGi and lgG2a responses in CD4 depleted mice when incorporated in the DNA vaccine platform. We have developed a prime boost vaccination platform that demonstrates efficacy against PC in CD4-depleted mice a codon optimized immunodominant antigen from PC, miniKexin, and CD40L as a molecular adjuvant. Both components were required for vaccine efficacy in the setting of CD4 deficiency. These results lead us to hypothesize that activation of CD40 signaling in vivo, and vaccination with miniKexin can result in antigen specific immune responses and mucosal boosting can provide effective vaccination against PCP in the absence of CD4+ T-cells.
Aim 1 : If our hypothesis is correct then co-administration of CD40L with mini-Kexin vaccination will result in a CD4 independent humoral response and protection against PC in vivo.
Aim 2 : Our hypothesis also predicts that this strategy requires endogenous IL-23 and IL-21, and results in durable vaccine responses in both CD4+ T-cell deficient mice and CD40L knockout mice.
Aim 3 : Test the hypothesis that CD41ND pathogen specific immune responses against P. carinii kexin can be generated in an SIV model of immunodeficiency in macaques.

Public Health Relevance

PCP remains a persistent and frequent complicafion of HIV and other immunosuppressive illnesses. The goal of this project is to develop therapeutic vaccine strategies to prevent this disease in immunocompromised hosts.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL076100-09
Application #
8529257
Study Section
Special Emphasis Panel (ZHL1-PPG-A)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
9
Fiscal Year
2013
Total Cost
$358,314
Indirect Cost
$105,981
Name
Louisiana State Univ Hsc New Orleans
Department
Type
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
Zheng, Mingquan; Cai, Yang; Eddens, Taylor et al. (2014) Novel pneumocystis antigen discovery using fungal surface proteomics. Infect Immun 82:2417-23
Chakraborty, Sourav; Cai, Yang; Tarr, Matthew A (2014) In vitro oxidative footprinting provides insight into apolipoprotein B-100 structure in low-density lipoprotein. Proteomics 14:2614-22
D'Souza, Alain J; Desai, Shyamal D; Rudner, Xiaowen L et al. (2013) Suppression of the macrophage proteasome by ethanol impairs MHC class I antigen processing and presentation. PLoS One 8:e56890
Kelly, Michelle N; Zheng, Mingquan; Ruan, Sanbao et al. (2013) Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. J Immunol 190:285-95
Patil, Ujwal S; Qu, Haiou; Caruntu, Daniela et al. (2013) Labeling primary amine groups in peptides and proteins with N-hydroxysuccinimidyl ester modified Fe3O4@SiO2 nanoparticles containing cleavable disulfide-bond linkers. Bioconjug Chem 24:1562-9
Porretta, Elizabeth; Happel, Kyle I; Teng, Xu S et al. (2012) The impact of alcohol on BCG-induced immunity against Mycobacterium tuberculosis. Alcohol Clin Exp Res 36:310-7
Auten, Matthew W; Huang, Weitao; Dai, Guixiang et al. (2012) CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals. Vaccine 30:2768-77
Shi, Xin; Zhang, Ping; Sempowski, Gregory D et al. (2011) Thymopoietic and bone marrow response to murine Pneumocystis pneumonia. Infect Immun 79:2031-42
Siggins, Robert W; Melvan, John N; Welsh, David A et al. (2011) Alcohol suppresses the granulopoietic response to pulmonary Streptococcus pneumoniae infection with enhancement of STAT3 signaling. J Immunol 186:4306-13
Shi, Xin; LeCapitaine, Nicole J; Rudner, Xiaowen L et al. (2009) Lymphocyte apoptosis in murine Pneumocystis pneumonia. Respir Res 10:57

Showing the most recent 10 out of 22 publications